Parkinson’s disease tagged posts

Parkinson’s Disease may start Before Birth

Clive Svendsen, PhD, director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, right, and Nur Yucer, PhD, a project scientist, discuss a microscope image of dopamine neurons. Photo by Cedars-Sinai.

Stem cell study finds malfunctioning brain cells in patients who were diagnosed before age 50; researchers test potential new treatment. People who develop Parkinson’s disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new Cedars-Sinai research. The research points to a drug that potentially might help correct these disease processes.

Parkinson’s occurs when brain neurons that make dopamine, a substance that helps coordinate muscle movement, become impaired or die...

Read More

Appendix identified as a potential Starting Point for Parkinson’s disease

ggregated alpha-synuclein in the neurons of the appendix. Credit: Courtesy of Viviane Labrie | Van Andel Research Institute

Aggregated alpha-synuclein in the neurons of the appendix.
Credit: Courtesy of Viviane Labrie | Van Andel Research Institute

Appendix acts as a reservoir for disease-associated proteins; appendectomy lowers the risk of developing Parkinson’s. Removing the appendix early in life reduces the risk of developing Parkinson’s disease by 19 to 25%, according to the largest and most comprehensive study of its kind, published today in Science Translational Medicine.

The findings also solidify the role of the gut and immune system in the genesis of the disease, and reveal that the appendix acts as a major reservoir for abnormally folded alpha-synuclein proteins, which are closely linked to Parkinson’s onset and progression.

“Our results point to the appendix as a site of origin for Parkinson’s and pr...

Read More

Scientists Unravel Molecular Mechanisms of Parkinson’s disease

Mitochondria Parkinson's disease

Image: super resolution image of α-synuclein in mitochondria of neuron (left) and single molecule TIRF image of individual α-synuclein aggregates (right). Credit: Mathew Horrocks

Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson’s disease. The study adds to our growing understanding of the causes of Parkinson’s and other neurodegenerative diseases, and could influence drug design in the future.

For years, scientists have known that Parkinson’s disease is associated with a build-up of alpha-synuclein protein inside brain cells. But how these protein clumps cause neurons to die was a mystery...

Read More

How the Gut Influences Neurologic Disease

AHR limits microglial pro-inflammatory transcriptional responses during EAE.

AHR limits microglial pro-inflammatory transcriptional responses during EAE.

A study published this week in Nature sheds new light on the connection between the gut and the brain, untangling the complex interplay that allows the byproducts of microorganisms living in the gut to influence the progression of neurodegenerative diseases. Investigators from Brigham and Women’s Hospital (BWH) have been using both animal models and human cells from patients to tease out the key players involved in the gut-brain connection as well as in the crosstalk between immune cells and brain cells. Their new publication defines a pathway that may help guide therapies for multiple sclerosis and other neurologic diseases.

The new research focuses on the influence of gut microbes on two types of cells that play...

Read More